Ad
EDIT Short Information Editas Medicine Inc.
home / stock / edit / edit short
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 2,861,440 |
| Total Actual Volume | 32,967,160 |
| Short Trends | |
|---|---|
| Cover Days | 5 |
| Short Days | 3 |
| No Change Days | 12 |
| Averages | |
|---|---|
| Average Short Volume | 143,072 |
| Average Short Percentage | 40.64% |
Is there a EDIT Short Squeeze or Breakout about to happen?
See the EDIT Short Analysis for free Sign up or Login
Powered by Squeeze Report
EDIT Twenty Trading Day's Volume to Short Volume Chart
EDIT Twenty Trading Day Price Chart
EDIT Short Data Results Days
| Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 2022-09-27 | 12.64 | 12.7 | 12.85 | 12.42 | 1,532,794 | 177,754 | 49.2625 |
| 2022-09-26 | 12.67 | 12.21 | 13.31 | 12.19 | 1,487,169 | 146,152 | 36.7275 |
| 2022-09-23 | 13.04 | 12.72 | 13.28 | 12.26 | 1,928,446 | 144,476 | 31.8286 |
| 2022-09-22 | 13.76 | 13.28 | 13.8001 | 12.91 | 1,553,787 | 122,033 | 32.1493 |
| 2022-09-21 | 14.7 | 13.91 | 14.93 | 13.9 | 1,426,627 | 107,497 | 39.5106 |
| 2022-09-20 | 14.3 | 14.61 | 14.81 | 14.3 | 1,044,872 | 78,253 | 33.3517 |
| 2022-09-19 | 14.3 | 14.58 | 14.75 | 13.93 | 1,505,556 | 139,467 | 39.6637 |
| 2022-09-16 | 15.65 | 14.435 | 15.7 | 14.25 | 4,057,269 | 251,826 | 55.4277 |
| 2022-09-15 | 14.55 | 16.11 | 16.16 | 14.53 | 2,309,008 | 183,365 | 33.7379 |
| 2022-09-14 | 14.85 | 14.68 | 14.85 | 14.19 | 2,111,673 | 136,176 | 37.8776 |
| 2022-09-13 | 15.25 | 14.815 | 15.35 | 14.34 | 2,275,689 | 279,434 | 54.3341 |
| 2022-09-12 | 15.87 | 15.99 | 16.04 | 15.31 | 1,348,326 | 134,407 | 40.4177 |
| 2022-09-09 | 16.22 | 15.83 | 16.3 | 15.48 | 1,072,168 | 98,807 | 37.0504 |
| 2022-09-08 | 15.61 | 16.2 | 16.39 | 15.48 | 1,387,445 | 126,814 | 46.2936 |
| 2022-09-07 | 14.32 | 15.85 | 15.86 | 14.32 | 1,560,613 | 123,433 | 40.2125 |
| 2022-09-06 | 15.01 | 14.3 | 15.06 | 14.14 | 1,270,645 | 156,587 | 51.2015 |
| 2022-09-01 | 14.523 | 15.42 | 15.43 | 14.1 | 1,322,365 | 160,788 | 46.2469 |
| 2022-08-31 | 15.39 | 14.7 | 15.49 | 14.68 | 1,357,999 | 97,215 | 35.2449 |
| 2022-08-30 | 15.25 | 15.12 | 15.379 | 14.61 | 1,075,183 | 77,333 | 30.7891 |
| 2022-08-29 | 14.58 | 14.88 | 15.2273 | 14.4838 | 1,339,526 | 119,623 | 41.4615 |
News, Short Squeeze, Breakout and More Instantly...
Ad
Ad
-
Shares of Editas Medicine (NASDAQ: EDIT) were rocketing more than 13% higher in late-afternoon trading on Wednesday, and it was little wonder. The company scored twin beats in its latest set of quarterly results, with one line item in particular being a standout. Prior to market...
-
Appointed Baisong Mei, M.D., Ph.D., Chief Medical Officer, strengthening senior leadership team Achieved successful engraftment of first patient treated with EDIT-301 for sickle cell disease; first clinical use of Editas-engineered AsCas12a enzyme FDA removed partial clini...
-
Successful engraftment of first patient dosed with EDIT-301 for sickle cell disease FDA removed partial clinical hold for the RUBY trial in EDIT-301 First clinical use of Editas-engineered AsCas12a enzyme Initial clinical data from the RUBY trial expected by year...
Ad
